drugset / Trial / NCT00565253

Inhaled Nitric Oxide in Pulmonary Embolism

NCT00565253

Phase 2 Completed 30 enrolled Medical University of Vienna
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the study is to determine if inhaled nitric oxide, a potent and selective pulmonary vasodilator, is beneficial in patients with acute pulmonary embolism causing increased right ventricular afterload.

Timeline

Start
2005-03
Primary completion
2009-07
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 20 ppm Inhaled

Indications